Trial intelligence / Profile preview

Formoterol Concept1 vs Aerolizer in Persistent Asthma

NCT00443482Phase 2Completed

Sponsor
Novartis
Start
Feb 2007
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of formoterol in asthma, sponsored by Novartis. Started Feb 2007; status: completed.

02

Drugs

formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00443482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00443482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call